Maze Therapeutics, Inc. (MAZE) Reports Q1 Loss of $1.15
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| (NASDAQ: MAZE) | Delayed: 31.69 +0.62 (2.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $31.07 | 52 Week High | $ | |||
| Open | $31.18 | 52 Week Low | $ | |||
| Day High | $32.01 | P/E | N/A | |||
| Day Low | $30.88 | EPS | $ | |||
| Volume | 624,988 | |||||
